See more : Aditya Birla Capital Limited (ABCAPITAL.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Theratechnologies Inc. (TH.TO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Theratechnologies Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Guangdong Shunna Electric Co., Ltd (000533.SZ) Income Statement Analysis – Financial Results
- Warrego Energy Limited (WGO.AX) Income Statement Analysis – Financial Results
- River Tech p.l.c. (RIVER.OL) Income Statement Analysis – Financial Results
- Vikas EcoTech Limited (VIKASECO.BO) Income Statement Analysis – Financial Results
- SIM Technology Group Limited (912000.TW) Income Statement Analysis – Financial Results
Theratechnologies Inc. (TH.TO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.theratech.com
About Theratechnologies Inc.
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH1902, which is in Phase 1/Part A clinical trials for the treatment of triple negative breast cancer; and TH1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 81.76M | 80.06M | 69.82M | 66.05M | 63.22M | 44.10M | 33.31M | 27.59M | 22.48M | 5.88M | 7.11M | 13.66M | 14.46M | 31.26M | 16.52M | 2.13M | 3.13M | 1.44M | 14.09M | 2.23M | 3.09M | 5.48M | 2.86M | 802.46K | 1.02M | 716.15K | 281.10K | 371.06K |
| Cost of Revenue | 19.64M | 26.28M | 23.26M | 26.90M | 26.08M | 12.97M | 7.98M | 4.96M | 3.01M | 2.14M | 3.50M | 5.09M | 8.86M | 460.02K | 0.00 | -514.42K | -1.57K | -204.41K | -2.37M | -418.02K | -919.71K | -3.09M | 151.94K | 75.56K | 203.73K | 195.31K | -118.90K | 148.42K |
| Gross Profit | 62.13M | 53.78M | 46.56M | 39.15M | 37.14M | 31.13M | 25.33M | 22.64M | 19.47M | 3.73M | 3.62M | 8.57M | 5.60M | 30.80M | 16.52M | 2.64M | 3.13M | 1.65M | 16.46M | 2.65M | 4.01M | 8.57M | 2.71M | 726.91K | 814.92K | 520.83K | 400.00K | 222.63K |
| Gross Profit Ratio | 75.99% | 67.17% | 66.69% | 59.27% | 58.75% | 70.58% | 76.03% | 82.04% | 86.61% | 63.53% | 50.87% | 62.73% | 38.73% | 98.53% | 100.00% | 124.19% | 100.05% | 114.15% | 116.80% | 118.74% | 129.80% | 156.49% | 94.69% | 90.58% | 80.00% | 72.73% | 142.30% | 60.00% |
| Research & Development | 30.37M | 36.94M | 28.27M | 18.02M | 10.84M | 7.78M | 9.21M | 5.18M | 3.67M | 4.90M | 6.94M | 6.38M | 10.64M | 13.79M | 21.01M | 28.45M | 31.85M | 18.48M | 11.79M | 14.29M | 18.69M | 15.10M | 8.87M | 4.22M | 3.19M | 2.86M | 2.95M | 2.67M |
| General & Administrative | 15.62M | 17.36M | 14.62M | 12.23M | 8.33M | 5.69M | 4.52M | 3.62M | 3.03M | 3.99M | 3.59M | 5.50M | 10.48M | 7.85M | 10.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 26.77M | 39.39M | 28.91M | 26.86M | 26.48M | 21.08M | 18.69M | 9.42M | 8.24M | 5.20M | 235.48K | 857.70K | 1.96M | 2.62M | 2.44M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 42.39M | 56.75M | 43.53M | 39.09M | 34.81M | 26.77M | 23.21M | 13.04M | 11.28M | 9.18M | 3.83M | 6.36M | 12.44M | 10.47M | 13.24M | 9.84M | 9.61M | 5.07M | 5.51M | 6.45M | 6.24M | 5.24M | 3.74M | 3.92M | 2.38M | 2.34M | 2.39M | 2.00M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.53M | 1.49M | 1.42M | -2.71M | 0.00 | 0.00 | 0.00 | 0.00 | -1.37M | 2.79M | -811.59K | 549.28K | 1.09M | 754.61K | -40.06K | 820.50K | -1.10M | -994.61K | -747.01K | -911.46K | -632.47K | -519.48K |
| Operating Expenses | 72.76M | 93.69M | 71.80M | 57.11M | 45.65M | 34.54M | 33.95M | 19.71M | 16.37M | 11.38M | 10.77M | 12.74M | 23.08M | 24.26M | 32.88M | 41.08M | 40.64M | 24.10M | 18.38M | 21.49M | 24.89M | 21.17M | 11.51M | 7.15M | 4.82M | 4.30M | 4.71M | 4.16M |
| Cost & Expenses | 92.39M | 119.97M | 95.06M | 84.01M | 71.73M | 47.51M | 41.93M | 24.66M | 19.38M | 13.52M | 14.27M | 17.83M | 31.94M | 24.72M | 32.88M | 41.08M | 40.64M | 24.10M | 18.38M | 21.49M | 24.89M | 21.17M | 11.66M | 7.22M | 5.03M | 4.49M | 4.71M | 4.30M |
| Interest Income | 0.00 | 316.00K | 195.00K | 299.00K | 1.10M | 595.74K | 262.65K | 77.41K | 30.66K | 172.86K | 428.57K | 917.10K | 1.55M | 1.53M | 4.26M | 2.43M | 2.50M | 1.45M | 1.61M | 2.38M | 3.81M | 5.08M | 3.80M | 2.20M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 10.55M | 6.50M | 5.66M | 5.36M | 4.99M | 2.48M | 1.07M | 1.44M | 1.87M | 1.05M | 416.32K | 917.10K | 615.92K | 17.66K | 4.26M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 3.32M | 12.47M | 8.75M | 8.52M | 7.50M | 4.15M | 1.55M | 1.57M | 1.43M | 997.00K | 113.97K | 567.78K | 321.52K | 775.86K | 578.61K | 4.85M | 1.11M | 915.46K | 1.32M | 1.10M | 13.21M | 1.44M | 627.48K | 300.27K | 203.73K | 65.10K | 140.55K | 74.21K |
| EBITDA | -9.86M | -27.83M | -17.25M | -9.18M | -11.00K | 788.00K | -6.85M | 4.54M | 4.62M | -7.13M | -3.68M | -3.60M | -17.16M | 8.84M | -13.73M | -36.41M | -36.40M | -21.74M | -2.97M | -18.16M | -14.46M | -14.25M | -8.18M | -6.12M | -3.80M | -3.71M | -4.29M | -3.93M |
| EBITDA Ratio | -12.06% | -33.92% | -23.38% | -13.89% | 0.06% | 2.29% | -20.55% | 16.45% | 20.54% | -110.26% | -140.29% | -19.67% | -107.97% | 28.29% | -95.59% | -1,625.52% | -1,163.88% | -1,504.91% | -77.78% | -812.16% | -468.42% | -137.72% | -1,172.83% | -1,854.63% | -373.33% | -581.82% | -1,375.00% | -1,120.00% |
| Operating Income | -10.63M | -39.91M | -25.24M | -17.96M | -7.46M | -3.42M | -8.62M | 2.93M | 3.10M | -11.23M | -4.22M | -14.95M | -18.18M | 6.54M | -14.24M | -38.95M | -37.51M | -22.66M | -4.29M | -19.26M | -32.13M | -15.69M | -8.80M | -6.42M | -4.01M | -3.78M | -4.43M | -3.93M |
| Operating Income Ratio | -13.00% | -49.85% | -36.14% | -27.19% | -11.79% | -7.75% | -25.89% | 10.62% | 13.79% | -191.16% | -59.35% | -109.43% | -125.72% | 20.91% | -86.20% | -1,831.69% | -1,197.54% | -1,568.28% | -30.44% | -863.34% | -1,041.19% | -286.44% | -307.83% | -800.00% | -393.33% | -527.27% | -1,575.00% | -1,060.00% |
| Total Other Income/Expenses | -12.91M | -6.89M | -6.43M | -4.69M | -3.98M | -2.41M | -5.71M | -2.15M | -1.50M | 2.10M | 437.83K | -9.86M | 935.50K | 2.34M | 1.50M | -465.42K | -56.97K | 0.00 | -7.99M | -1.51M | -7.46M | 6.71M | 8.80M | 6.42M | 0.00 | 455.73K | 421.64K | 371.06K |
| Income Before Tax | -23.54M | -46.79M | -31.66M | -22.65M | -12.50M | -5.78M | -14.34M | 780.77K | 1.60M | -9.18M | -3.79M | -14.03M | -17.24M | 8.87M | 0.00 | -39.42M | -37.57M | 0.00 | -12.28M | -20.77M | -27.67M | -8.98M | 16.56M | 2.34M | 0.00 | -3.32M | -4.01M | -3.64M |
| Income Before Tax Ratio | -28.79% | -58.45% | -45.35% | -34.29% | -19.77% | -13.11% | -43.04% | 2.83% | 7.12% | -156.12% | -53.34% | -102.71% | -119.25% | 28.38% | 0.00% | -1,853.58% | -1,199.36% | 0.00% | -87.13% | -930.92% | -896.61% | -163.92% | 579.12% | 292.05% | 0.00% | -463.64% | -1,425.00% | -980.00% |
| Income Tax Expense | 421.00K | 443.00K | 63.00K | 16.00K | 4.99M | -1.25M | 1.07M | 475.61K | 425.54K | 27.06K | 24.49K | 5.03K | -69.73K | 111.82K | -2.13M | -465.42K | -56.97K | 0.11 | -7.99M | -1.51M | -2.43M | 182.76K | -25.78M | -10.19M | -679.10K | -455.73K | 421.64K | -222.63K |
| Net Income | -23.96M | -47.24M | -31.73M | -22.67M | -17.49M | -4.53M | -14.34M | 305.16K | 1.17M | -9.20M | -3.82M | -14.03M | -17.17M | 8.76M | -14.24M | -39.42M | -37.57M | -22.66M | -12.28M | -19.22M | -25.25M | -9.16M | 16.98M | 3.77M | -3.33M | -3.32M | -4.01M | -3.49M |
| Net Income Ratio | -29.30% | -59.00% | -45.44% | -34.32% | -27.66% | -10.27% | -43.04% | 1.11% | 5.23% | -156.58% | -53.69% | -102.75% | -118.77% | 28.02% | -86.20% | -1,853.58% | -1,199.36% | -1,568.28% | -87.13% | -861.31% | -818.02% | -167.26% | 593.71% | 470.29% | -326.67% | -463.64% | -1,425.00% | -940.00% |
| EPS | -0.91 | -0.50 | -0.34 | -0.29 | -0.23 | -0.06 | -0.20 | 0.01 | 0.02 | -0.15 | -0.06 | -0.23 | -0.28 | 0.15 | -0.24 | -0.69 | -0.71 | -0.53 | -0.34 | -0.56 | -0.82 | -0.30 | 0.62 | 0.16 | -0.16 | -0.18 | -0.24 | -0.24 |
| EPS Diluted | -0.91 | -0.50 | -0.34 | -0.29 | -0.23 | -0.06 | -0.20 | 0.01 | 0.02 | -0.15 | -0.06 | -0.23 | -0.28 | 0.15 | -0.24 | -0.69 | -0.71 | -0.53 | -0.34 | -0.54 | -0.82 | -0.30 | 0.60 | 0.16 | -0.16 | -0.18 | -0.24 | -0.24 |
| Weighted Avg Shares Out | 26.33M | 95.25M | 92.35M | 76.99M | 76.93M | 75.94M | 73.47M | 65.81M | 62.49M | 61.01M | 61.01M | 60.98M | 60.73M | 60.48M | 60.31M | 57.42M | 52.58M | 43.10M | 35.86M | 34.57M | 30.92M | 30.50M | 27.57M | 24.62M | 20.42M | 18.21M | 16.76M | 14.69M |
| Weighted Avg Shares Out (Dil) | 26.33M | 95.25M | 92.35M | 76.99M | 76.93M | 75.94M | 73.47M | 66.60M | 63.17M | 61.01M | 61.01M | 60.98M | 60.73M | 61.32M | 60.31M | 57.42M | 52.58M | 43.10M | 35.86M | 35.48M | 30.92M | 30.50M | 28.37M | 26.90M | 20.42M | 18.21M | 16.76M | 14.69M |
No news found for: TH.TO
Source: https://incomestatements.info
Category: Stock Reports